Canada markets closed

Surgery Partners, Inc. (SGRY)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
56.35+0.42 (+0.75%)
At close: 4:00PM EDT
Currency in USD

Valuation Measures

Market Cap (intraday) 54.65B
Enterprise Value 37.51B
Trailing P/E N/A
Forward P/E 1281.75
PEG Ratio (5 yr expected) 1-216.61
Price/Sales (ttm)2.41
Price/Book (mrq)9.79
Enterprise Value/Revenue 33.89
Enterprise Value/EBITDA 724.41

Trading Information

Stock Price History

Beta (5Y Monthly) 3.18
52-Week Change 3259.60%
S&P500 52-Week Change 336.19%
52 Week High 369.58
52 Week Low 314.98
50-Day Moving Average 362.86
200-Day Moving Average 347.67

Share Statistics

Avg Vol (3 month) 3373.11k
Avg Vol (10 day) 3425.11k
Shares Outstanding 582.5M
Implied Shares Outstanding 660.2M
Float 22.07M
% Held by Insiders 12.55%
% Held by Institutions 1138.89%
Shares Short (Jun. 29, 2021) 42.1M
Short Ratio (Jun. 29, 2021) 44.7
Short % of Float (Jun. 29, 2021) 43.88%
Short % of Shares Outstanding (Jun. 29, 2021) 42.54%
Shares Short (prior month May 27, 2021) 41.8M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Mar. 30, 2021

Profitability

Profit Margin -5.67%
Operating Margin (ttm)10.81%

Management Effectiveness

Return on Assets (ttm)2.43%
Return on Equity (ttm)1.17%

Income Statement

Revenue (ttm)1.93B
Revenue Per Share (ttm)38.36
Quarterly Revenue Growth (yoy)16.20%
Gross Profit (ttm)379.8M
EBITDA 307.6M
Net Income Avi to Common (ttm)-149.9M
Diluted EPS (ttm)-2.98
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)541.9M
Total Cash Per Share (mrq)9.27
Total Debt (mrq)3.24B
Total Debt/Equity (mrq)174.85
Current Ratio (mrq)1.77
Book Value Per Share (mrq)5.76

Cash Flow Statement

Operating Cash Flow (ttm)267.9M
Levered Free Cash Flow (ttm)172.16M